[{"id":"017f4e5c-8797-41eb-a091-490f05ee1c48","acronym":"MFI2-PREDICT","url":"https://clinicaltrials.gov/study/NCT04946266","created_at":"2021-06-30T17:54:26.774Z","updated_at":"2024-07-02T16:36:18.800Z","phase":"","brief_title":"Prospective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney Cancers","source_id_and_acronym":"NCT04946266 - MFI2-PREDICT","lead_sponsor":"University Hospital, Strasbourg, France","biomarkers":" MELTF","pipe":" | ","alterations":" MFI2 expression","tags":["MELTF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MFI2 expression"],"overall_status":"Recruiting","enrollment":" Enrollment 260","initiation":"Initiation: 12/01/2021","start_date":" 12/01/2021","primary_txt":" Primary completion: 12/01/2021","primary_completion_date":" 12/01/2021","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2022-01-05"},{"id":"2a18b389-bb1e-4b11-9a58-ae4a0ebee432","acronym":"HEARTO","url":"https://clinicaltrials.gov/study/NCT01348412","created_at":"2024-01-07T00:16:56.371Z","updated_at":"2024-07-02T16:37:08.945Z","phase":"Phase 2","brief_title":"Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure","source_id_and_acronym":"NCT01348412 - HEARTO","lead_sponsor":"Centre Georges Francois Leclerc","biomarkers":" MELTF","pipe":"","alterations":" ","tags":["MELTF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e oxaliplatin • Tomudex (raltitrexed)"],"overall_status":"Completed","enrollment":" Enrollment 31","initiation":"Initiation: 12/15/2010","start_date":" 12/15/2010","primary_txt":" Primary completion: 12/15/2010","primary_completion_date":" 12/15/2010","study_txt":" Completion: 04/18/2018","study_completion_date":" 04/18/2018","last_update_posted":"2018-07-16"}]